Prostate Cancer - Results from #140

Assessment of bone mineral density in men with de novo metastatic castration-sensitive prostate cancer treated with or without abiraterone acetate plus prednisone in the PEACE-1 phase 3 trial. February 12, 2025

Feasibility and Short-Term Safety of Hydrogel Spacer before Treatment with Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation for Prostate Cancer Treatment. February 12, 2025

Development of a deep learning system for predicting biochemical recurrence in prostate cancer. February 12, 2025

Adjuvant radiation therapy or observation with or without early salvage radiation therapy for men with node positive prostate cancer after surgery and negative pre-operative conventional imaging: a multicenter study. February 12, 2025

Comparative Performance of Machine Learning Models in Reducing Unnecessary Targeted Prostate Biopsies. February 11, 2025

Cellular Proliferation Imaging With 18F-FMAU PET/CT as Adjunct to mpMRI in Image-Guided Biopsy of Suspected Prostate Cancer. February 11, 2025

Integrating Prostate Surface Membrane Antigen-PET into Clinical Practice for Prostate Cancer. February 11, 2025

SleepNow - A combined cognitive behavioral therapy for insomnia and physical exercise intervention in men with metastatic prostate cancer: results from a feasibility randomized controlled trial. February 11, 2025

An App-Based Intervention With Behavioral Support to Promote Brisk Walking in People Diagnosed With Breast, Prostate, or Colorectal Cancer (APPROACH): Process Evaluation Study. February 11, 2025

Incorporating Structured and Unstructured Data Sources to Identify and Characterize Hereditary Cancer Testing Among Veterans With Metastatic Castration-Resistant Prostate Cancer. February 11, 2025

Integrating radiological and clinical data for clinically significant prostate cancer detection with machine learning techniques. February 10, 2025

ATAD2 Drives Prostate Cancer Progression to Metastasis. February 10, 2025

Implementing and Optimizing Universal Germline Genetic Testing for Patients with Prostate Cancer in Clinical Practice Consider. February 10, 2025

Mitochondrial KMT9 methylates DLAT to control pyruvate dehydrogenase activity and prostate cancer growth. February 10, 2025

MR-guided Transrectal Focal Laser Ablation for Localized Low- and Intermediate Risk Prostate Cancer: Initial Outcomes Using an Integrated Laser Ablation System. February 10, 2025

Long-term outcomes of LDR-brachytherapy for localized prostate cancer. February 10, 2025

Associations between socioeconomic factors and PSA testing in a population-based organised testing programme and routine healthcare: a register-based study of 50-year-old men. February 10, 2025

Omission of Contralateral Systematic Biopsies in Unilateral Suspicious Prostate Cancer on Magnetic Resonance Imaging: Implications for Radiation Treatment Selection. February 10, 2025

Utility of 18F-DCFPyL PET for local staging for high or very high risk prostate cancer for patients undergoing radical prostatectomy. February 10, 2025

New rectum dose surface mapping methodology to identify rectal subregions associated with toxicities following prostate cancer radiotherapy. February 10, 2025

Page 8 of 1465